News and Opinion
September 14, 2023
Amgen, MSD and Gilead feature in IPHA’s campaign that demonstrates the promise of science through animation style storytelling. Thursday, 14th September 2023 The Irish Pharmaceutical Healthcare […]
July 3, 2023
Last Friday, June 30th, IPHA published the Transfer of value (ToV) Disclosure data for 2022. The total ToV amount for 2022 was €26,140,927 which is a […]
April 28, 2023
In 2022, it took on average 567 days from EMA authorisation to availability to patients of new innovative medicines in Ireland, among the slowest in western […]
March 15, 2023
The Irish Pharmaceutical Healthcare Association (IPHA) is pleased to announce the appointment of Eimear O’Leary, PhD as Director of Communications and Advocacy. Eimear previously held the […]
March 2, 2023
Irish Pharmaceutical Healthcare Association Annual Conference An Tánaiste, Micheál Martin TD Thank you Michael for your very warm and suspiciously complimentary introduction. And good evening ladies […]
March 2, 2023
Irish Pharmaceutical Healthcare Association (IPHA) Annual Conference, Mansion House Dublin, March 2, 2023. Good morning, I’m delighted to join you at your annual conference. I’d like […]
March 2, 2023
Annual Conference to assess innovation pipeline and supportive policies Proposals from the European Commission to weaken intellectual property rights will degrade the development and delivery of […]
February 24, 2023
The decision by Minister for Health, Stephen Donnelly T.D. to publish the Mazars Report today has been welcomed by the Irish Pharmaceutical Healthcare Association as a […]
December 5, 2022
61% would follow doctor’s advice on vaccination 51% have received two or more booster Covid-19 vaccine doses 77% believe children should study science at school Almost […]